Patrick Brady, Vice President for Regulatory Policy & Intelligence at Bayer, discusses the impact of artificial intelligence on clinical and regulatory science professionals. Mr. Brady will moderate the panel discussion <a href="http://www.diaglobal.org/Flagship/EuroMeeting//Program/Search-Program/Event-Details?meetingid=6493386&productID=7172882&eventType=Session" target="_blank">Exploring the Use of Artificial Intelligence: Trust in Technology, or Trust in Each Other?</a> at <a href="http://www.diaglobal.org/en/flagship/euromeeting" target="_blank">DIA Europe 2018</a>.

Patrick Brady, Vice President for Regulatory Policy & Intelligence at Bayer, discusses the impact of artificial intelligence on clinical and regulatory science professionals. Mr. Brady will moderate the panel discussion Exploring the Use of Artificial Intelligence: Trust in Technology, or Trust in Each Other? at DIA Europe 2018.

Patrick Brady, Vice President for Regulatory Policy &amp; Intelligence at Bayer, discusses the impact of artificial intelligence on clinical and regulatory science professionals. Mr. Brady will moderate the panel discussion <a href="http://www.diaglobal.org/Flagship/EuroMeeting//Program/Search-Program/Event-Details?meetingid=6493386&amp;productID=7172882&amp;eventType=Session" rel="noopener noreferrer">Exploring the Use of Artificial Intelligence: Trust in Technology, or Trust in Each Other?</a> at <a href="http://www.diaglobal.org/en/flagship/euromeeting" rel="noopener noreferrer">DIA Europe 2018</a>.

Will AI Make Workers More (or Less) Valuable?

DIA is a global, multidisciplinary, membership association of healthcare professionals that works towards the advancement of lifesaving medicines, therapies, and technologies around the world.

Share Will AI Make Workers More (or Less) Valuable?

Sign up to save your podcasts

Will AI Make Workers More (or Less) Valuable?

Will AI Make Workers More (or Less) Valuable?